Hair Follicle Neogenesis Treatment
Androgenetic Alopecia (Male and Female Pattern Hair Loss)
Phase 2Active
Key Facts
Indication
Androgenetic Alopecia (Male and Female Pattern Hair Loss)
Phase
Phase 2
Status
Active
Company
About Follica
Follica is a private, clinical-stage biotech pioneering a regenerative medicine platform for dermatology, with a primary focus on androgenetic alopecia (pattern hair loss). The company's core technology involves a proprietary combination of epidermal disruption and topical drug formulations to reprogram skin cells and generate new hair follicles. Having progressed its lead program into later-stage clinical trials, Follica is positioned to address a significant unmet need in the multi-billion dollar hair restoration market. Its platform also holds potential for broader applications in skin regeneration and wound healing.
View full company profile